Martin Kräter

Martin Kräter studied Biology and Cell Biology & Genetics at Leipzig University, receiving his M.Sc. in Medical Microbiology and Virology. Following research at the German Cancer Research Center, he earned his Ph.D. in Hematopoietic Stem Cell Development from TU Dresden in 2017 (summa cum laude). He subsequently joined Jochen Guck’s group, pioneering the application of Deformability Cytometry to blood cell research. At the Max Planck Institute for the Science of Light and the Max Planck Center for Physics and Medicine in Erlangen, he became a laboratory manager and leading researcher in microfluidic blood diagnostics. He has authored over 30 peer-reviewed publications and received the German Society for Cell Biology Young Scientist Award (2019) and Medical Valley Award (2020). In 2022, he co-founded Rivercyte GmbH, where he serves as CEO, advancing Deformability Cytometry toward clinical diagnostics.